Earnings Feed
Sign Up
Home/Insiders/KESSEL MARK
KM
SEC Insider//CIK 0001222013

KESSEL MARK

CIK 00012220133 companiesSOUTH SAN FRANCISCO, CA
SEC Profile

Transactions

10

Companies

3

Filings

6

CIK

0001222013

Recent Transactions

10 trades
  • Award
    Oncotelic Therapeutics, Inc.$OTLC

    Common Stock, $0.01 par value per share

    2011-01-02$0.23/sh+25,000→ 115,000 total
  • Award
    Oncotelic Therapeutics, Inc.$OTLC

    Common Stock, $0.01 par value per share

    2011-01-02$0.23/sh+25,000→ 115,000 total
  • Award
    Oncotelic Therapeutics, Inc.$OTLC

    Common Stock, $0.01 par value per share

    2010-01-02$1.14/sh+35,000→ 65,000 total
  • Award
    DYNAVAX TECHNOLOGIES CORP$DVAX

    Option (Right to Buy)

    2009-12-30+20,000→ 20,000 total
  • Award
    DYNAVAX TECHNOLOGIES CORP$DVAX

    Option (Right to Buy)

    2009-12-30+20,000→ 20,000 total
  • Award
    AGENUS INC$AGEN

    Deferred Shares

    2006-01-13$5.19/sh+1,253.098→ 62,579.885 total
  • Award
    AGENUS INC$AGEN

    Deferred Shares

    2006-01-13$5.19/sh+1,253.098→ 62,579.885 total
  • Award
    AGENUS INC$AGEN

    Deferred Shares

    2005-01-14$8.63/sh+3,360.371→ 43,360.371 total
  • Award
    AGENUS INC$AGEN

    Stock Option (right to buy)

    2004-05-27$8.41/sh+22,800→ 40,000 total
  • Award
    AGENUS INC$AGEN

    Stock Option (right to buy)

    2004-05-27$8.41/sh+22,800→ 40,000 total

Companies

3

Recent Filings

6

Address

C/O OXIGENE, INC. 701 GATEWAY BLVD.

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov